3Falk K, Bjorquist P, Stromqvist M, et al. Reduction of experimental adhesion formation by inhibition of p]asminogen activator inhibitor type 1. Br J Surg, 2001, 88(2): 286-289.
4Yarali H, Zahradka BF, Gomel V. Hyaluronic acid membrane for reducing adhesion formation and reformation in the rat uterine horn. J Reprod Med, 1994, 39(6): 667-670.
5Tanaka A, Abe T, Matsuura A. Prevention of postoperative intrapleural adhesion of the thoracotomy incision by a bioresorbable membrane in the rat adhesion model. Ann Thorac Cardiovasc Surg, 2000, 6(3): 151-160.
6Bernard L T C, Both J. Searching for tuberculosis in the pleural space [J] .Chest, 1999,116(1) :3 - 4.
7Canete C, Granados I, Farrero E ,et al. Tuberculous plersl effusion:experience with six months of treatment with isoniazid and rifampicin [J] , Thorax, 1994,49:1160-1161.
5Kita T, Watanabe S, Yano F, et al. Clinical significance of the serum IL-2R level and Ga-67 Man findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma. Ann Nucl Med, 2007, 21(9):499-503.
6Kiropoulos TS, Kostikas K, Oikonomidi S, et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med, 2007, 101(5):910-918.
7Karapanou V, Kempuraj D, Theoharides TC. Interleukin-8 is increased in gingival erevicular fluid from patients with acute pulpitis. J Endod, 2008, 34(2):148-151.
8Cozmei C, Constantinescu D, Carasevici E, et al. Th1 and Th2 cytokine response in patients with pulmonary tuberculosis and health care workers occupationally exposed to M. tuberculosis. Rev Med Chir Soc Med Nat Iasi, 2007, 111 (3):702-709.
9Lockyer HM, Tran E, Nelson BH. STAT5 is essential for Akt/p- 70S6 kinase activity during IL-2-induced lymphocyte proliferation. J Immunol, 2007, 179(8):5301-5308.
10Seiscento M, Vargas FS, Antonangelo L, et al. Transforming growth factor beta-1 as a predictor of fibrosis in tuberculous pleurisy. Respirology, 2007, 12(5):660-663.
